Page:ICD-10-CM (2010).djvu/225

 3 Tumor lysis syndrome
 * Tumor lysis syndrome (spontaneous)
 * Tumor lysis syndrome following antineoplastic drug chemotherapy
 * Code first (T45.1-) to identify drug, if drug induced
 * E88.4 Mitochondrial metabolism disorders
 * Excludes1: disorders of pyruvate metabolism (E74.4)
 * Kearns-Sayre syndrome (H49.81)
 * Leber's disease (H47.22)
 * Leigh's encephalopathy (G31.82)
 * Mitochondrial myopathy, NEC (G71.3)
 * Reye's syndrome (G93.7)
 * E88.40 Mitochondrial metabolism disorder, unspecified
 * E88.41 MELAS syndrome
 * Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
 * E88.42 MERRF syndrome
 * Myoclonic epilepsy associated with ragged-red fibers
 * Code also: myoclonic epilepsy (G40.3-)
 * E88.49 Other mitochondrial metabolism disorders
 * E88.8 Other specified metabolic disorders
 * E88.81 Metabolic syndrome
 * Dysmetabolic syndrome X
 * E88.89 Other specified metabolic disorders
 * Launois-Bensaude adenolipomatosis
 * E88.9 Metabolic disorder, unspecified

E89 Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified

 * Excludes2: intraoperative complications of endocrine system organ or structure (E36.0-, E36.1-, E36.8)
 * E89.0 Postprocedural hypothyroidism
 * Postirradiation hypothyroidism
 * Postsurgical hypothyroidism
 * E89.1 Postprocedural hypoinsulinemia
 * Postpancreatectomy hyperglycemia
 * Postsurgical hypoinsulinemia
 * Use additional code, if applicable, to identify:
 * acquired absence of pancreas (Z90.89)
 * diabetes mellitus (E11.-)
 * insulin use (Z79.4)
 * Excludes1: transient postprocedural hyperglycemia (R73.9)
 * transient postprocedural hypoglycemia (E16.2)
 * E89.2 Postprocedural hypoparathyroidism
 * Parathyroprival tetany
 * E89.3 Postprocedural hypopituitarism
 * Postirradiation hypopituitarism
 * E89.